Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $9.23 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.44.
Market Cap
9.23T
Revenue
4.66T
Profits
186.65B
PE Ratio
49.44
Profit Margin
4.00%
Dividend Yield
0.38%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | 0.25% | 1,723,603 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 632.29B | 0.78% | 5,502,559 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 442.36B | 0.35% | 4,521,494 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 355.11B | -1.52% | 3,903,149 | 450.53B |
| 5 | MRK | Merck & Co., Inc. | 335.46B | 0.10% | 8,441,506 | 66.57B |
| 6 | NVS | Novartis AG | 286.74B | 0.72% | 1,194,983 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 243.06B | 0.28% | 3,231,575 | 61.37B |
| 8 | AMGN | Amgen Inc. | 226.73B | 1.00% | 2,556,446 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 216.49B | -0.47% | 885,796 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 200.40B | -1.32% | 13,804,203 | 50.34B |
| 11 | ABT | Abbott Laboratories | 190.98B | -0.79% | 9,843,685 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 172.25B | 0.40% | 3,936,323 | 30.46B |
| 13 | PFE | Pfizer Inc. | 153.15B | 0.30% | 29,126,205 | 63.70B |
| 14 | DHR | Danaher Corporation | 142.45B | 0.09% | 2,980,649 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 137.90B | -1.06% | 2,148,541 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 132.02B | 1.25% | 7,278,865 | 49.19B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 130.67B | 1.94% | 1,109,811 | 12.59B |
| 18 | SYK | Stryker Corporation | 127.22B | -2.22% | 2,285,521 | 25.84B |
| 19 | CVS | CVS Health Corporation | 120.24B | -3.24% | 7,291,064 | 412.65B |
| 20 | MDT | Medtronic plc | 115.97B | -0.73% | 7,828,133 | 36.36B |
| 21 | SNY | Sanofi | 106.39B | 1.58% | 1,917,970 | 55.89B |
| 22 | GSK | GSK plc | 100.57B | 1.53% | 2,798,676 | 44.05B |
| 23 | MCK | McKesson Corporation | 100.26B | -1.04% | 1,136,687 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 87.68B | 0.07% | 1,005,063 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 84.63B | -2.52% | 900,151 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.48B | 0.30% | 541,105 | 15.53B |
| 27 | BSX | Boston Scientific Corporation | 74.53B | -0.77% | 18,105,127 | 21.00B |
| 28 | CI | The Cigna Group | 72.75B | -2.56% | 892,725 | 282.38B |
| 29 | ARGX | argenx SE | 61.95B | 16.04% | 668,753 | 5.32B |
| 30 | COR | Cencora, Inc. | 59.64B | -0.41% | 981,112 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 55.24B | -1.42% | 2,370,229 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 54.81B | 0.21% | 1,795,061 | 254.25B |
| 33 | EW | Edwards Lifesciences Corporation | 52.34B | -0.86% | 2,214,944 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 49.60B | -0.71% | 1,293,391 | 22.48B |
| 35 | HUM | Humana Inc. | 46.15B | -1.22% | 749,940 | 145.68B |
| 36 | MDLN | Medline Inc. | 45.86B | -2.41% | 3,697,893 | 29.94B |
| 37 | RVMD | Revolution Medicines, Inc. | 45.44B | 4.07% | 2,435,687 | - |
| 38 | NTRA | Natera, Inc. | 45.29B | 1.37% | 927,254 | 2.71B |
| 39 | IDXX | IDEXX Laboratories, Inc. | 43.02B | -0.88% | 570,816 | 4.55B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 42.49B | -0.84% | 3,240,846 | 17.32B |
| 41 | A | Agilent Technologies, Inc. | 41.93B | -0.05% | 964,506 | 7.23B |
| 42 | HLN | Haleon plc | 41.82B | -1.24% | 3,881,728 | 14.80B |
| 43 | ONC | BeOne Medicines AG | 41.22B | 4.33% | 431,983 | 6.13B |
| 44 | WAT | Waters Corporation | 40.06B | -1.07% | 608,442 | 4.64B |
| 45 | IQV | IQVIA Holdings Inc. | 39.71B | 1.94% | 1,507,103 | 16.98B |
| 46 | VEEV | Veeva Systems Inc. | 38.72B | -2.22% | 1,005,312 | 3.32B |
| 47 | ALC | Alcon Inc. | 35.14B | -2.37% | 1,277,162 | 10.86B |
| 48 | RPRX | Royalty Pharma plc | 34.18B | 1.45% | 2,356,305 | 2.54B |
| 49 | DXCM | DexCom, Inc. | 33.49B | -1.10% | 3,970,519 | 4.97B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 32.69B | -1.79% | 2,236,435 | 21.27B |
| 51 | CNC | Centene Corporation | 31.82B | -4.54% | 2,601,272 | 180.30B |
| 52 | RMD | ResMed Inc. | 31.79B | -1.82% | 1,419,935 | 5.65B |
| 53 | BIIB | Biogen Inc. | 30.90B | -0.32% | 616,727 | 10.03B |
| 54 | ZTS | Zoetis Inc. | 30.15B | -1.11% | 6,540,868 | 9.53B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.05B | -1.77% | 1,538,275 | 4.80B |
| 56 | ILMN | Illumina, Inc. | 29.16B | 1.18% | 995,679 | 4.49B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.40B | -0.11% | 107,533 | 4.13B |
| 58 | INSM | Insmed Incorporated | 28.02B | 3.70% | 1,895,209 | 1.14B |
| 59 | PHG | Koninklijke Philips N.V. | 26.78B | -1.72% | 863,652 | 20.18B |
| 60 | LH | Labcorp Holdings Inc. | 26.22B | 1.64% | 772,257 | 14.35B |
| 61 | ROIV | Roivant Sciences Ltd. | 26.18B | 0.11% | 7,707,829 | 7.53M |
| 62 | DGX | Quest Diagnostics Incorporated | 26.00B | 0.48% | 578,244 | 11.56B |
| 63 | MRNA | Moderna, Inc. | 25.73B | 1.80% | 3,879,666 | 2.23B |
| 64 | INCY | Incyte Corporation | 25.03B | 2.78% | 2,039,208 | 5.82B |
| 65 | WST | West Pharmaceutical Services, Inc. | 24.39B | -0.80% | 282,527 | 3.33B |
| 66 | BNTX | BioNTech SE | 23.01B | -1.60% | 441,294 | 3.03B |
| 67 | STE | STERIS plc | 22.40B | -1.51% | 603,655 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 21.81B | 1.75% | 457,324 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 21.70B | 2.84% | 4,857,335 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.30B | -1.25% | 643,135 | 21.81B |
| 71 | GMAB | Genmab A/S | 19.46B | 2.82% | 3,415,748 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.73B | -2.43% | 1,750,466 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.64B | - | 7,883,487 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 16.67B | 3.22% | 162,394 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.25B | -0.44% | 607,386 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.12B | 1.39% | 504,156 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.70B | 1.16% | 1,168,027 | 3.37B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 15.62B | 0.04% | 2,795,423 | 713.07M |
| 79 | SOLV | Solventum Corporation | 14.78B | -2.00% | 1,521,383 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.65B | -1.40% | 1,268,045 | 4.23B |
| 81 | CRL | Charles River Laboratories International, Inc. | 13.68B | 2.35% | 855,189 | 4.00B |
| 82 | BAX | Baxter International Inc. | 13.40B | -3.07% | 5,838,725 | 11.47B |
| 83 | ICLR | ICON Public Limited Company | 13.07B | 3.86% | 484,497 | 8.29B |
| 84 | EXEL | Exelixis, Inc. | 12.96B | 2.11% | 2,372,324 | 2.44B |
| 85 | RVTY | Revvity, Inc. | 12.96B | -0.57% | 729,263 | 2.91B |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 12.90B | -1.07% | 2,235,494 | 3.41B |
| 87 | PEN | Penumbra, Inc. | 12.89B | 0.05% | 187,634 | 1.50B |
| 88 | CORT | Corcept Therapeutics Incorporated | 12.67B | 2.36% | 536,462 | 830.81M |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.58B | -2.16% | 1,610,501 | 14.37B |
| 90 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.53B | 2.38% | 929,152 | 669.50M |
| 91 | FMS | Fresenius Medical Care AG | 12.52B | -1.14% | 531,308 | 22.19B |
| 92 | SNN | Smith & Nephew plc | 12.41B | -0.44% | 773,953 | 6.30B |
| 93 | ALGN | Align Technology, Inc. | 12.16B | -5.60% | 915,990 | 4.14B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.13B | 3.41% | 307,245 | 1.28B |
| 95 | EHC | Encompass Health Corporation | 12.03B | -1.29% | 863,985 | 6.21B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.80B | -0.25% | 6,854,525 | 5.02B |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.69B | 4.40% | 2,174,824 | 1.66B |
| 98 | GMED | Globus Medical, Inc. | 11.43B | -0.91% | 1,081,613 | 3.14B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 11.33B | 1.22% | 511,605 | 776.57M |
| 100 | TECH | Bio-Techne Corporation | 11.28B | -0.01% | 2,925,453 | 1.22B |
| 101 | DVA | DaVita Inc. | 11.27B | -1.87% | 472,313 | 14.01B |
| 102 | GKOS | Glaukos Corporation | 10.94B | 0.59% | 723,510 | 612.84M |
| 103 | MOH | Molina Healthcare, Inc. | 10.58B | -4.41% | 617,526 | 42.47B |
| 104 | ABVX | ABIVAX Société Anonyme | 10.57B | 1.49% | 874,300 | 5.67M |
| 105 | CYTK | Cytokinetics, Incorporated | 10.55B | 2.35% | 1,489,242 | 67.67M |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 10.51B | 2.61% | 580,327 | 7.46M |
| 107 | ENSG | The Ensign Group, Inc. | 10.49B | -0.03% | 213,437 | 5.49B |
| 108 | RDY | Dr. Reddy's Laboratories Limited | 10.38B | -1.30% | 2,041,123 | 3.50B |
| 109 | PTGX | Protagonist Therapeutics, Inc. | 10.26B | 2.27% | 506,926 | 281.99M |
| 110 | SMMT | Summit Therapeutics Inc. | 10.20B | -4.27% | 9,841,191 | - |
| 111 | APGE | Apogee Therapeutics, Inc. | 10.15B | 0.03% | 1,636,823 | - |
| 112 | KYMR | Kymera Therapeutics, Inc. | 10.10B | 3.42% | 704,143 | 105.00M |
| 113 | UHS | Universal Health Services, Inc. | 10.05B | 0.30% | 589,940 | 18.11B |
| 114 | HSIC | Henry Schein, Inc. | 9.98B | -0.28% | 1,255,503 | 13.60B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.94B | 1.04% | 254,769 | 440.48M |
| 116 | IONS | Ionis Pharmaceuticals, Inc. | 9.74B | 2.43% | 1,997,936 | 874.09M |
| 117 | OSCR | Oscar Health, Inc. | 9.73B | -3.69% | 5,899,837 | 15.32B |
| 118 | PODD | Insulet Corporation | 9.69B | -2.54% | 1,947,356 | 3.05B |
| 119 | RGEN | Repligen Corporation | 9.54B | 1.35% | 654,714 | 785.10M |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 9.50B | -0.29% | 213,496 | 2.59B |
| 121 | TEM | Tempus AI, Inc. | 9.32B | -0.88% | 2,773,577 | 1.43B |
| 122 | SYRE | Spyre Therapeutics, Inc. | 9.22B | 0.94% | 891,394 | - |
| 123 | AVTR | Avantor, Inc. | 9.13B | -1.17% | 4,536,194 | 6.56B |
| 124 | IMVT | Immunovant, Inc. | 9.03B | 4.52% | 1,039,816 | - |
| 125 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | 0.06% | 1,631,472 | 42.16M |
| 126 | PCVX | Vaxcyte, Inc. | 8.96B | 3.70% | 712,161 | - |
| 127 | QGEN | Qiagen N.V. | 8.81B | -0.81% | 3,191,787 | 2.10B |
| 128 | BRKR | Bruker Corporation | 8.79B | -0.05% | 1,807,880 | 3.50B |
| 129 | HQY | HealthEquity, Inc. | 8.56B | -2.29% | 716,096 | 1.34B |
| 130 | IBRX | ImmunityBio, Inc. | 8.39B | 4.62% | 6,770,813 | 165.79M |
| 131 | ATR | AptarGroup, Inc. | 8.38B | -0.27% | 361,194 | 3.93B |
| 132 | ALKS | Alkermes plc | 8.36B | 1.61% | 761,725 | 1.67B |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.95B | -0.03% | 410,834 | 239.92M |
| 134 | TWST | Twist Bioscience Corporation | 7.80B | 4.93% | 975,702 | 431.80M |
| 135 | TXG | 10x Genomics, Inc. | 7.56B | 3.39% | 2,254,448 | 616.91M |
| 136 | ORKA | Oruka Therapeutics, Inc. | 7.46B | 1.46% | 511,921 | - |
| 137 | HNGE | Hinge Health, Inc. | 7.09B | -0.70% | 1,220,952 | 720.06M |
| 138 | PACS | PACS Group, Inc. | 7.02B | -0.27% | 696,909 | 5.55B |
| 139 | TGTX | TG Therapeutics, Inc. | 6.99B | 1.11% | 1,055,710 | 799.54M |
| 140 | LQDA | Liquidia Corporation | 6.95B | 4.38% | 1,514,876 | 450.91M |
| 141 | GRFS | Grifols, S.A. | 6.86B | -0.13% | 293,750 | 8.48B |
| 142 | CGON | CG Oncology, Inc. | 6.84B | 2.77% | 958,277 | 6.23M |
| 143 | CHE | Chemed Corporation | 6.83B | -1.48% | 113,083 | 2.60B |
| 144 | HIMS | Hims & Hers Health, Inc. | 6.68B | 1.63% | 10,214,990 | 2.58B |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.59B | -0.04% | 767,315 | 1.56B |
| 146 | COGT | Cogent Biosciences, Inc. | 6.57B | -0.16% | 1,593,968 | - |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.48B | -0.80% | 407,608 | 618.07M |
| 148 | DNTH | Dianthus Therapeutics, Inc. | 6.42B | -0.95% | 581,188 | 1.90M |
| 149 | BLTE | Belite Bio, Inc | 6.42B | 0.25% | 176,828 | - |
| 150 | ERAS | Erasca, Inc. | 6.39B | -0.54% | 2,223,620 | - |
| 151 | SRRK | Scholar Rock Holding Corporation | 6.34B | -0.89% | 738,435 | - |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.18B | 3.17% | 319,109 | 840.85M |
| 153 | CAI | Caris Life Sciences, Inc. | 6.11B | -0.78% | 2,767,823 | 989.61M |
| 154 | PTCT | PTC Therapeutics, Inc. | 6.08B | 1.65% | 981,116 | 1.01B |
| 155 | DFTX | Definium Therapeutics, Inc. | 6.08B | 6.17% | 2,271,841 | - |
| 156 | BLCO | Bausch + Lomb Corporation | 6.07B | -0.29% | 407,601 | 5.32B |
| 157 | XENE | Xenon Pharmaceuticals Inc. | 6.04B | 0.02% | 678,457 | 7.50M |
| 158 | TVTX | Travere Therapeutics, Inc. | 5.99B | 2.24% | 1,560,506 | 591.33M |
| 159 | RDNT | RadNet, Inc. | 5.98B | -0.55% | 592,361 | 2.27B |
| 160 | AMRX | Amneal Pharmaceuticals, Inc. | 5.88B | 1.49% | 1,620,144 | 3.12B |
| 161 | LGND | Ligand Pharmaceuticals Incorporated | 5.82B | -0.96% | 142,590 | 290.54M |
| 162 | STVN | Stevanato Group S.p.A. | 5.81B | 0.95% | 560,176 | 1.40B |
| 163 | TFX | Teleflex Incorporated | 5.64B | -2.99% | 685,941 | 2.25B |
| 164 | MMED | MiniMed Group, Inc. | 5.48B | -3.08% | 1,516,017 | 3.10B |
| 165 | SHC | Sotera Health Company | 5.37B | -0.48% | 7,823,006 | 1.22B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.36B | -1.13% | 673,929 | 1.58B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.25B | 1.36% | 951,185 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.00B | 2.73% | 834,256 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.88B | 1.75% | 1,306,257 | - |
| 170 | LFST | LifeStance Health Group, Inc. | 4.79B | 1.05% | 3,447,991 | 1.58B |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.78B | -0.29% | 751,351 | - |
| 172 | WAY | Waystar Holding Corp. | 4.73B | -0.40% | 1,364,618 | 1.21B |
| 173 | INDV | Indivior Pharmaceuticals, Inc. | 4.61B | 0.18% | 2,017,826 | 1.33B |
| 174 | PBLS | Parabilis Medicines, Inc. | 4.60B | 0.40% | 384,885 | 148.00K |
| 175 | ICUI | ICU Medical, Inc. | 4.56B | -0.26% | 281,306 | 2.16B |
| 176 | CON | Concentra Group Holdings Parent, Inc. | 4.53B | 0.28% | 731,846 | 2.29B |
| 177 | RLAY | Relay Therapeutics, Inc. | 4.53B | 4.08% | 1,828,170 | 10.35M |
| 178 | CELC | Celcuity Inc. | 4.52B | 0.48% | 1,081,269 | - |
| 179 | MANE | Veradermics, Incorporated | 4.52B | -3.98% | 576,166 | - |
| 180 | LIVN | LivaNova PLC | 4.49B | -0.90% | 443,534 | 1.47B |
| 181 | NVST | Envista Holdings Corporation | 4.44B | -1.53% | 2,834,899 | 2.86B |
| 182 | BLLN | BillionToOne, Inc. | 4.43B | 0.62% | 488,209 | 397.41M |
| 183 | DOCS | Doximity, Inc. | 4.37B | -1.13% | 3,405,397 | 655.57M |
| 184 | ELVN | Enliven Therapeutics, Inc. | 4.36B | 1.22% | 526,255 | - |
| 185 | TNGX | Tango Therapeutics, Inc. | 4.26B | -1.21% | 2,210,526 | 53.81M |
| 186 | ITGR | Integer Holdings Corporation | 4.25B | -0.14% | 429,795 | 1.84B |
| 187 | HAE | Haemonetics Corporation | 4.11B | -0.58% | 463,769 | 1.35B |
| 188 | LEGN | Legend Biotech Corporation | 3.99B | 1.37% | 1,266,911 | 1.27B |
| 189 | TLX | Telix Pharmaceuticals Limited | 3.97B | -0.76% | 59,021 | 803.79M |
| 190 | ADPT | Adaptive Biotechnologies Corporation | 3.95B | 0.12% | 2,667,229 | 308.08M |
| 191 | VKTX | Viking Therapeutics, Inc. | 3.92B | 1.33% | 1,514,469 | - |
| 192 | DNLI | Denali Therapeutics Inc. | 3.89B | -0.20% | 997,251 | 3.60M |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.85B | -7.53% | 751,922 | 825.34M |
| 194 | GPCR | Structure Therapeutics Inc. | 3.83B | -1.38% | 303,191 | - |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.76B | 0.27% | 2,171,228 | 117.00M |
| 196 | HTFL | HeartFlow, Inc. | 3.65B | -0.33% | 3,450,489 | 212.07M |
| 197 | ABCL | AbCellera Biologics Inc. | 3.63B | -1.58% | 7,408,642 | 66.17M |
| 198 | OGN | Organon & Co. | 3.60B | -0.15% | 1,982,807 | 6.13B |
| 199 | NHC | National HealthCare Corporation | 3.57B | 2.06% | 93,101 | 1.56B |
| 200 | IDYA | IDEAYA Biosciences, Inc. | 3.53B | 0.66% | 427,442 | 234.13M |
| 201 | OPCH | Option Care Health, Inc. | 3.50B | -2.40% | 2,507,085 | 5.69B |
| 202 | VCYT | Veracyte, Inc. | 3.38B | 2.01% | 1,319,686 | 561.90M |
| 203 | PLSE | Pulse Biosciences, Inc. | 3.34B | 5.05% | 492,272 | 1.19M |
| 204 | QURE | uniQure N.V. | 3.33B | -1.34% | 832,149 | 18.67M |
| 205 | ALMS | Alumis Inc. | 3.30B | 0.75% | 732,165 | 7.40M |
| 206 | CLDX | Celldex Therapeutics, Inc. | 3.29B | -0.07% | 624,360 | 158.00K |
| 207 | MBX | MBX Biosciences, Inc. | 3.29B | -0.47% | 449,685 | - |
| 208 | ARQT | Arcutis Biotherapeutics, Inc. | 3.22B | -2.21% | 1,662,821 | 463.98M |
| 209 | IOVA | Iovance Biotherapeutics, Inc. | 3.22B | 1.72% | 13,906,567 | 324.97M |
| 210 | NAMS | NewAmsterdam Pharma Company N.V. | 3.22B | -0.30% | 834,280 | 7.12M |
| 211 | WRBY | Warby Parker Inc. | 3.16B | -1.20% | 2,208,398 | 911.61M |
| 212 | GRAL | GRAIL, Inc. | 3.12B | 3.06% | 774,841 | 165.26M |
| 213 | IMNM | Immunome, Inc. | 3.11B | 0.74% | 1,149,883 | 4.02M |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 3.10B | 2.04% | 540,417 | 606.33M |
| 215 | IRON | Disc Medicine, Inc. | 3.07B | 1.53% | 382,055 | - |
| 216 | TMDX | TransMedics Group, Inc. | 3.06B | -0.26% | 513,485 | 668.47M |
| 217 | BKD | Brookdale Senior Living Inc. | 2.92B | -3.24% | 3,900,135 | 2.93B |
| 218 | ZLAB | Zai Lab Limited | 2.88B | -1.00% | 1,350,104 | 449.61M |
| 219 | NRIX | Nurix Therapeutics, Inc. | 2.82B | 0.44% | 1,151,462 | 36.77M |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.81B | - | 526,445 | 830.44M |
| 221 | ACHC | Acadia Healthcare Company, Inc. | 2.79B | -2.69% | 1,461,551 | 3.37B |
| 222 | ALHC | Alignment Healthcare, Inc. | 2.79B | -3.58% | 3,473,416 | 4.58B |
| 223 | AVAH | Aveanna Healthcare Holdings Inc. | 2.77B | 3.00% | 3,724,962 | 2.60B |
| 224 | PRVA | Privia Health Group, Inc. | 2.75B | -2.27% | 865,450 | 2.36B |
| 225 | BEAM | Beam Therapeutics Inc. | 2.71B | 1.31% | 1,445,009 | 156.04M |
| 226 | ATAI | AtaiBeckley Inc. | 2.69B | -0.28% | 7,533,802 | 4.47M |
| 227 | RGC | Regencell Bioscience Holdings Limited | 2.65B | -1.83% | 182,086 | - |
| 228 | AXGN | Axogen, Inc. | 2.64B | 0.86% | 631,892 | 251.17M |
| 229 | TRVI | Trevi Therapeutics, Inc. | 2.63B | 0.11% | 867,077 | - |
| 230 | SLS | SELLAS Life Sciences Group, Inc. | 2.63B | 1.72% | 5,316,976 | - |
| 231 | VRDN | Viridian Therapeutics, Inc. | 2.62B | 4.57% | 1,630,109 | 71.13M |
| 232 | NEOG | Neogen Corporation | 2.59B | 1.89% | 1,066,167 | 870.40M |
| 233 | KOD | Kodiak Sciences Inc. | 2.57B | -0.89% | 611,211 | - |
| 234 | RARE | Ultragenyx Pharmaceutical Inc. | 2.57B | -1.36% | 1,312,022 | 717.00M |
| 235 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.54B | 2.05% | 2,117,206 | 940.61M |
| 236 | COAG | Hemab Therapeutics Holdings, Inc. | 2.50B | -2.46% | 208,312 | - |
| 237 | UFPT | UFP Technologies, Inc. | 2.49B | -0.14% | 89,002 | 631.64M |
| 238 | NKTR | Nektar Therapeutics | 2.48B | -0.48% | 681,488 | 54.59M |
| 239 | PHVS | Pharvaris N.V. | 2.48B | 0.51% | 556,779 | - |
| 240 | BHC | Bausch Health Companies Inc. | 2.46B | 1.08% | 2,067,947 | 10.85B |
| 241 | GRDN | Guardian Pharmacy Services, Inc. | 2.41B | -1.12% | 459,320 | 1.46B |
| 242 | URGN | UroGen Pharma Ltd. | 2.40B | 1.91% | 1,283,596 | 188.73M |
| 243 | BFLY | Butterfly Network, Inc. | 2.40B | 2.04% | 3,361,944 | 112.14M |
| 244 | KLRA | Kailera Therapeutics, Inc. | 2.40B | 3.18% | 644,361 | - |
| 245 | CDNA | CareDx, Inc. | 2.40B | 2.34% | 726,331 | 458.09M |
| 246 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.39B | -0.92% | 1,153,965 | -665.00K |
| 247 | PBH | Prestige Consumer Healthcare Inc. | 2.37B | -2.61% | 567,233 | 1.10B |
| 248 | PGEN | Precigen, Inc. | 2.35B | 7.38% | 6,271,775 | 85.72M |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.34B | 6.08% | 10,307,189 | 52.06M |
| 250 | RAPP | Rapport Therapeutics, Inc. | 2.32B | 2.11% | 154,027 | 20.00M |
| 251 | WGS | GeneDx Holdings Corp. | 2.31B | -0.88% | 431,850 | 454.43M |
| 252 | MLYS | Mineralys Therapeutics, Inc. | 2.30B | 1.60% | 800,108 | - |
| 253 | ESTA | Establishment Labs Holdings Inc. | 2.28B | -3.59% | 409,595 | 245.82M |
| 254 | VERA | Vera Therapeutics, Inc. | 2.28B | - | 2,347,859 | - |
| 255 | ATRC | AtriCure, Inc. | 2.28B | 1.06% | 966,248 | 569.62M |
| 256 | NUVB | Nuvation Bio Inc. | 2.28B | 4.18% | 5,051,083 | 169.90M |
| 257 | CLOV | Clover Health Investments, Corp. | 2.27B | -7.17% | 4,898,463 | 2.48B |
| 258 | MESO | Mesoblast Limited | 2.26B | 9.14% | 456,786 | 65.38M |
| 259 | HCM | HUTCHMED (China) Limited | 2.24B | 2.95% | 85,826 | 549.12M |
| 260 | VCEL | Vericel Corporation | 2.23B | -1.38% | 276,156 | 306.30M |
| 261 | XRAY | DENTSPLY SIRONA Inc. | 2.23B | -3.45% | 3,681,664 | 3.64B |
| 262 | ALMR | Alamar Biosciences, Inc. | 2.23B | -3.11% | 193,457 | 100.42M |
| 263 | HRMY | Harmony Biosciences Holdings, Inc. | 2.22B | 0.05% | 733,758 | 959.90M |
| 264 | PVLA | Palvella Therapeutics, Inc. | 2.21B | -1.67% | 185,417 | - |
| 265 | BHVN | Biohaven Ltd. | 2.18B | -1.23% | 1,849,116 | - |
| 266 | ADUS | Addus HomeCare Corporation | 2.10B | -1.00% | 155,320 | 1.48B |
| 267 | ADMA | ADMA Biologics, Inc. | 2.09B | -1.37% | 1,436,797 | 512.28M |
| 268 | MD | Pediatrix Medical Group, Inc. | 2.09B | -1.01% | 613,124 | 1.95B |
| 269 | NBTX | Nanobiotix S.A. | 2.08B | 9.76% | 521,391 | 38.27M |
| 270 | NEO | NeoGenomics, Inc. | 2.08B | 1.38% | 742,023 | 766.30M |
| 271 | STOK | Stoke Therapeutics, Inc. | 2.07B | 2.75% | 442,784 | 27.59M |
| 272 | SEPN | Septerna, Inc. | 2.06B | -0.67% | 433,264 | 98.88M |
| 273 | GHRS | GH Research PLC | 2.06B | 1.66% | 182,169 | - |
| 274 | NVCR | NovoCure Limited | 2.04B | 3.42% | 1,448,071 | 699.19M |
| 275 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | -1.16% | 995,774 | 311.51M |
| 276 | ASTH | Astrana Health, Inc. | 2.03B | -2.60% | 478,407 | 3.84B |
| 277 | TSHA | Taysha Gene Therapies, Inc. | 2.02B | 4.37% | 3,049,636 | 5.49M |
| 278 | GENB | Generate Biomedicines, Inc. | 2.01B | 0.32% | 737,860 | 26.48M |
| 279 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | 0.21% | 968,231 | 98.34M |
| 280 | ZBIO | Zenas BioPharma, Inc. | 1.99B | 3.35% | 489,882 | 1.00M |
| 281 | PGNY | Progyny, Inc. | 1.94B | -3.61% | 711,029 | 1.31B |
| 282 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.08% | 557,765 | - |
| 283 | KARD | Kardigan, Inc. | 1.92B | 1.73% | 179,768 | - |
| 284 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | 0.44% | 1,671,586 | 1.97B |
| 285 | DMRA | Damora Therapeutics, Inc. | 1.92B | 0.16% | 362,688 | - |
| 286 | CMPS | COMPASS Pathways plc | 1.90B | 2.01% | 1,790,373 | - |
| 287 | LMAT | LeMaitre Vascular, Inc. | 1.89B | 0.16% | 266,591 | 262.43M |
| 288 | SGRY | Surgery Partners, Inc. | 1.86B | -4.46% | 2,421,321 | 3.37B |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.85B | -0.31% | 336,155 | 481.07M |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.84B | -0.04% | 422,896 | 1.13B |
| 291 | TRLV | Trulieve Cannabis Corp. | 1.82B | -1.87% | 748,655 | 1.14B |
| 292 | IMCR | Immunocore Holdings plc | 1.81B | 2.46% | 261,462 | 430.78M |
| 293 | ZYME | Zymeworks Inc. | 1.80B | 0.76% | 440,361 | 37.13M |
| 294 | PRGO | Perrigo Company plc | 1.78B | -1.69% | 2,136,103 | 4.14B |
| 295 | BRVE | Braveheart Bio, Inc. | 1.77B | 2.33% | 310,138 | - |
| 296 | ANAB | AnaptysBio, Inc. | 1.77B | 2.09% | 247,889 | 232.39M |
| 297 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -0.40% | 1,092,139 | 252.25M |
| 298 | ETON | Eton Pharmaceuticals, Inc. | 1.76B | 4.88% | 1,248,000 | 105.60M |
| 299 | BLFS | BioLife Solutions, Inc. | 1.73B | 1.08% | 394,014 | 106.69M |
| 300 | FTRE | Fortrea Holdings Inc. | 1.72B | 3.96% | 1,145,464 | 2.68B |
| 301 | XNCR | Xencor, Inc. | 1.72B | -0.94% | 914,812 | 104.97M |
| 302 | AVLN | Avalyn Pharma Inc. | 1.70B | -2.55% | 148,861 | - |
| 303 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 1.51% | 1,793,259 | 59.51M |
| 304 | RXRX | Recursion Pharmaceuticals, Inc. | 1.67B | -1.58% | 9,836,624 | 54.86M |
| 305 | INSP | Inspire Medical Systems, Inc. | 1.65B | 0.21% | 514,546 | 898.74M |
| 306 | AAPG | Ascentage Pharma Group International | 1.65B | -4.21% | 5,862 | 82.08M |
| 307 | BCAX | Bicara Therapeutics Inc. | 1.65B | 2.72% | 433,617 | - |
| 308 | OMCL | Omnicell, Inc. | 1.64B | -3.40% | 885,149 | 1.25B |
| 309 | KMTS | Kestra Medical Technologies, Ltd. | 1.63B | -0.71% | 193,666 | 95.13M |
| 310 | ANIP | ANI Pharmaceuticals, Inc. | 1.63B | -0.71% | 259,249 | 978.38M |
| 311 | AGL | agilon health, inc. | 1.63B | -0.04% | 191,794 | 5.92B |
| 312 | VIR | Vir Biotechnology, Inc. | 1.59B | 1.62% | 1,459,048 | 303.23M |
| 313 | ABSI | Absci Corporation | 1.59B | 0.65% | 2,105,234 | 1.56M |
| 314 | SLBT | SL Science Holding Limited | 1.57B | 3.76% | 22,390 | 3.27M |
| 315 | TYRA | Tyra Biosciences, Inc. | 1.56B | 3.68% | 595,702 | - |
| 316 | TRAX | First Tracks Biotherapeutics, Inc. | 1.56B | -1.00% | 486,266 | - |
| 317 | XERS | Xeris Biopharma Holdings, Inc. | 1.55B | -0.93% | 1,334,161 | 335.41M |
| 318 | MAZE | Maze Therapeutics, Inc. | 1.55B | 2.83% | 322,038 | 20.00M |
| 319 | TNDM | Tandem Diabetes Care, Inc. | 1.55B | -2.05% | 1,183,550 | 1.04B |
| 320 | ARDT | Ardent Health, Inc. | 1.54B | -0.18% | 219,833 | 6.41B |
| 321 | INVA | Innoviva, Inc. | 1.51B | -1.09% | 617,914 | 440.00M |
| 322 | JBIO | Jade Biosciences, Inc. | 1.49B | -5.10% | 669,149 | - |
| 323 | LBRX | LB Pharmaceuticals Inc | 1.49B | -3.23% | 261,444 | - |
| 324 | PSNL | Personalis, Inc. | 1.48B | -1.07% | 1,091,525 | 69.67M |
| 325 | HCSG | Healthcare Services Group, Inc. | 1.48B | - | 788,041 | 1.86B |
| 326 | HROW | Harrow, Inc. | 1.48B | -1.39% | 322,031 | 275.59M |
| 327 | CNMD | CONMED Corporation | 1.48B | -2.30% | 448,818 | 1.37B |
| 328 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.47B | -0.35% | 2,145,102 | 208.78M |
| 329 | AZTA | Azenta, Inc. | 1.47B | 0.60% | 525,462 | 613.81M |
| 330 | FRNM | Freenome, Inc. | 1.47B | 12.46% | 1,890,615 | 34.24M |
| 331 | ATEC | Alphatec Holdings, Inc. | 1.46B | -3.47% | 1,397,731 | 815.05M |
| 332 | OMDA | Omada Health, Inc. | 1.45B | -1.21% | 944,605 | 309.76M |
| 333 | INNV | InnovAge Holding Corp. | 1.45B | 0.57% | 175,510 | 949.17M |
| 334 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -1.69% | 454,468 | - |
| 335 | ENOV | Enovis Corporation | 1.43B | -5.07% | 1,089,169 | 2.30B |
| 336 | PAHC | Phibro Animal Health Corporation | 1.40B | 0.79% | 152,550 | 1.50B |
| 337 | MLTX | MoonLake Immunotherapeutics | 1.39B | -0.73% | 1,198,754 | - |
| 338 | ORIC | ORIC Pharmaceuticals, Inc. | 1.39B | -3.53% | 1,145,258 | - |
| 339 | ALVO | Alvotech | 1.38B | -4.32% | 590,661 | 562.04M |
| 340 | AORT | Artivion, Inc. | 1.38B | -2.81% | 496,087 | 471.47M |
| 341 | REPL | Replimune Group, Inc. | 1.38B | -2.27% | 3,729,591 | - |
| 342 | AKTS | Aktis Oncology, Inc. | 1.37B | -0.84% | 162,799 | 10.06M |
| 343 | IART | Integra LifeSciences Holdings Corporation | 1.37B | -3.71% | 393,908 | 1.65B |
| 344 | PNTG | The Pennant Group, Inc. | 1.37B | -0.36% | 222,340 | 1.10B |
| 345 | SVRA | Savara Inc. | 1.36B | -0.19% | 1,204,085 | - |
| 346 | VOR | Vor Biopharma Inc. | 1.36B | -0.09% | 790,122 | - |
| 347 | INBX | Inhibrx Biosciences, Inc. | 1.35B | 4.12% | 230,630 | 1.30M |
| 348 | AMN | AMN Healthcare Services, Inc. | 1.34B | 0.12% | 469,418 | 3.43B |
| 349 | NVAX | Novavax, Inc. | 1.33B | 0.25% | 1,911,245 | 413.80M |
| 350 | CGEM | Cullinan Therapeutics, Inc. | 1.33B | 1.23% | 894,390 | - |
| 351 | MGTX | MeiraGTx Holdings plc | 1.32B | 1.85% | 816,795 | 397.50M |
| 352 | ANRO | Alto Neuroscience, Inc. | 1.32B | 4.54% | 863,508 | - |
| 353 | APMD | Apnimed, Inc. | 1.31B | 3.87% | 517,125 | 120.15M |
| 354 | GLUE | Monte Rosa Therapeutics, Inc. | 1.31B | -0.77% | 813,483 | 28.73M |
| 355 | DRTS | Alpha Tau Medical Ltd. | 1.31B | -0.70% | 418,370 | - |
| 356 | SPTX | Seaport Therapeutics, Inc. | 1.31B | 0.74% | 98,612 | - |
| 357 | SDGR | Schrödinger, Inc. | 1.30B | -1.08% | 646,374 | 259.04M |
| 358 | NUTX | Nutex Health Inc. | 1.29B | 0.53% | 142,081 | 846.72M |
| 359 | GDRX | GoodRx Holdings, Inc. | 1.27B | -0.27% | 1,306,419 | 785.23M |
| 360 | IMTX | Immatics N.V. | 1.26B | -2.01% | 1,067,651 | 43.00M |
| 361 | OMER | Omeros Corporation | 1.26B | 0.99% | 2,457,502 | 38.42M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | 0.13% | 395,013 | - |
| 363 | MNKD | MannKind Corporation | 1.25B | 1.30% | 3,320,073 | 393.63M |
| 364 | LTGO | Latigo Biotherapeutics, Inc. | 1.22B | -0.97% | 171,913 | - |
| 365 | CERT | Certara, Inc. | 1.22B | - | 4,654,597 | 421.75M |
| 366 | STAA | STAAR Surgical Company | 1.21B | -7.98% | 1,536,796 | 339.59M |
| 367 | PRCT | PROCEPT BioRobotics Corporation | 1.21B | -2.59% | 998,029 | 337.34M |
| 368 | TDOC | Teladoc Health, Inc. | 1.19B | -3.96% | 4,099,804 | 2.49B |
| 369 | USPH | U.S. Physical Therapy, Inc. | 1.17B | -3.40% | 205,394 | 804.27M |
| 370 | BVS | Bioventus Inc. | 1.17B | -2.66% | 715,869 | 581.85M |
| 371 | CRON | Cronos Group Inc. | 1.16B | 0.32% | 1,139,178 | 179.09M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | -1.75% | 572,864 | 1.04B |
| 373 | IRMD | IRADIMED CORPORATION | 1.13B | 1.23% | 105,768 | 86.34M |
| 374 | IVA | Inventiva S.A. | 1.11B | 2.17% | 551,628 | 7.94M |
| 375 | SANA | Sana Biotechnology, Inc. | 1.10B | 3.66% | 1,386,408 | - |
| 376 | GMRS | GMR Solutions Inc. | 1.08B | 3.98% | 511,454 | 5.88B |
| 377 | AVTX | Avalo Therapeutics, Inc. | 1.07B | 1.84% | 646,508 | 59.00K |
| 378 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.04B | 0.86% | 3,524,274 | 41.47M |
| 379 | AHG | Akso Health Group | 1.04B | -4.72% | 25,744 | 13.83M |
| 380 | OPK | OPKO Health, Inc. | 1.02B | -1.45% | 3,030,330 | 587.90M |
| 381 | ARDX | Ardelyx, Inc. | 1.01B | - | 3,663,981 | 450.89M |
| 382 | KURA | Kura Oncology, Inc. | 1.00B | 3.87% | 2,032,929 | 77.23M |
| 383 | WVE | Wave Life Sciences Ltd. | 1.00B | -5.91% | 3,234,647 | 65.37M |
| 384 | CLYM | Climb Bio, Inc. | 1.00B | 6.80% | 1,861,531 | - |
| 385 | QDEL | QuidelOrtho Corporation | 999.83M | 1.96% | 1,196,922 | 2.67B |
| 386 | ODTX | Odyssey Therapeutics, Inc. | 999.58M | 0.63% | 119,425 | 99.00K |
| 387 | JANX | Janux Therapeutics, Inc. | 994.08M | 0.87% | 539,148 | 24.00M |
| 388 | GERN | Geron Corporation | 982.98M | 4.08% | 8,404,200 | 204.56M |
| 389 | ATTO | Attovia Therapeutics, Inc. | 977.19M | 14.35% | 149,464 | 1.35M |
| 390 | SLDB | Solid Biosciences Inc. | 975.75M | -1.09% | 692,738 | - |
| 391 | ANNX | Annexon, Inc. | 972.54M | -3.02% | 3,623,389 | - |
| 392 | DSGN | Design Therapeutics, Inc. | 944.98M | 1.82% | 544,249 | - |
| 393 | OLMA | Olema Pharmaceuticals, Inc. | 942.35M | 1.32% | 889,655 | - |
| 394 | CBLL | CeriBell, Inc. | 936.43M | 4.59% | 396,159 | 101.96M |
| 395 | ABUS | Arbutus Biopharma Corporation | 931.86M | 0.86% | 1,210,386 | 181.72M |
| 396 | CADL | Candel Therapeutics, Inc. | 930.47M | 3.75% | 2,157,324 | - |
| 397 | PCRX | Pacira BioSciences, Inc. | 926.39M | 1.04% | 551,597 | 746.16M |
| 398 | AVR | Anteris Technologies Global Corp. | 918.06M | 0.21% | 482,999 | 2.24M |
| 399 | CSTL | Castle Biosciences, Inc. | 914.96M | 1.11% | 225,560 | 357.28M |
| 400 | COLL | Collegium Pharmaceutical, Inc. | 913.84M | -0.57% | 864,735 | 808.21M |
| 401 | AMPH | Amphastar Pharmaceuticals, Inc. | 887.34M | -0.24% | 532,048 | 730.02M |
| 402 | DBVT | DBV Technologies S.A. | 880.92M | 4.64% | 182,594 | 5.04M |
| 403 | TBPH | Theravance Biopharma, Inc. | 878.47M | -0.29% | 263,179 | 104.31M |
| 404 | ACRS | Aclaris Therapeutics, Inc. | 871.42M | 2.42% | 1,085,389 | 8.22M |
| 405 | TALK | Talkspace, Inc. | 870.58M | - | - | 245.73M |
| 406 | GLAS | Glass House Brands Inc. | 869.02M | 2.98% | 249,438 | 177.68M |
| 407 | SLN | Silence Therapeutics plc | 864.00M | 4.59% | 999,995 | 615.00K |
| 408 | INMD | InMode Ltd. | 863.36M | -0.86% | 548,302 | 374.63M |
| 409 | SGP | SpyGlass Pharma, Inc. | 862.29M | -1.60% | 59,524 | - |
| 410 | FTH | Faeth Therapeutics, Inc. | 846.79M | 1.33% | 406,309 | - |
| 411 | PHAR | Pharming Group N.V. | 839.53M | 0.60% | 17,208 | 366.48M |
| 412 | SIBN | SI-BONE, Inc. | 837.66M | -1.27% | 481,547 | 213.60M |
| 413 | HSTM | HealthStream, Inc. | 819.30M | -3.18% | 125,736 | 321.12M |
| 414 | IMMX | Immix Biopharma, Inc. | 811.26M | 3.37% | 1,246,771 | - |
| 415 | OCS | Oculis Holding AG | 811.16M | 1.55% | 220,185 | 1.45M |
| 416 | FDMT | 4D Molecular Therapeutics, Inc. | 803.53M | 19.32% | 3,438,762 | 92.01M |
| 417 | AURA | Aura Biosciences, Inc. | 796.45M | -0.13% | 3,819,267 | - |
| 418 | RIGL | Rigel Pharmaceuticals, Inc. | 792.96M | -0.31% | 426,511 | 276.79M |
| 419 | BBNX | Beta Bionics, Inc. | 790.02M | -0.06% | 1,265,551 | 119.01M |
| 420 | MNPR | Monopar Therapeutics Inc. | 781.90M | 3.05% | 170,908 | - |
| 421 | VREX | Varex Imaging Corporation | 778.05M | -0.16% | 1,063,940 | 865.00M |
| 422 | AHCO | AdaptHealth Corp. | 775.11M | - | 2,145,257 | 3.36B |
| 423 | ACHV | Achieve Life Sciences, Inc. | 771.77M | -1.19% | 940,197 | - |
| 424 | DRUG | Bright Minds Biosciences Inc. | 762.98M | 3.98% | 311,695 | - |
| 425 | OBX | Obsidian Therapeutics, Inc. | 759.73M | -1.32% | 18,465 | - |
| 426 | SSII | SS Innovations International, Inc. | 752.49M | -3.34% | 23,419 | 52.40M |
| 427 | CTMX | CytomX Therapeutics, Inc. | 751.75M | 2.68% | 2,362,385 | 18.30M |
| 428 | CBIO | Crescent Biopharma, Inc. | 748.16M | 1.98% | 126,116 | 11.88M |
| 429 | RGNX | REGENXBIO Inc. | 747.93M | 5.25% | 1,037,652 | 174.48M |
| 430 | STTK | Shattuck Labs, Inc. | 741.68M | -0.40% | 569,104 | 1.00M |
| 431 | PHAT | Phathom Pharmaceuticals, Inc. | 737.11M | -3.13% | 1,135,692 | 239.66M |
| 432 | NGNE | Neurogene Inc. | 734.02M | 1.49% | 90,969 | 925.00K |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 724.78M | -0.22% | 249,856 | - |
| 434 | GYRE | Gyre Therapeutics, Inc. | 722.09M | 1.95% | 47,647 | 109.82M |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 720.45M | 1.16% | 1,363,669 | 389.32M |
| 436 | ALLO | Allogene Therapeutics, Inc. | 718.62M | 1.46% | 4,653,585 | 4.64M |
| 437 | HELP | Cybin Inc. | 717.16M | -3.50% | 1,251,302 | - |
| 438 | PHR | Phreesia, Inc. | 715.78M | -5.70% | 1,091,982 | 495.59M |
| 439 | EVO | Evotec SE | 706.63M | - | 27,200 | 819.47M |
| 440 | ZVRA | Zevra Therapeutics, Inc. | 684.69M | 1.86% | 753,655 | 136.07M |
| 441 | VALN | Valneva SE | 674.85M | -0.98% | 135,431 | 163.30M |
| 442 | AGMB | AgomAb Therapeutics NV | 673.71M | 3.48% | 119,261 | - |
| 443 | TECX | Tectonic Therapeutic, Inc. | 661.75M | -3.04% | 143,883 | - |
| 444 | VSTM | Verastem, Inc. | 650.25M | 9.12% | 2,279,956 | 87.53M |
| 445 | SOPH | SOPHiA GENETICS SA | 649.53M | 1.73% | 202,736 | 86.17M |
| 446 | SGMT | Sagimet Biosciences Inc. | 648.31M | -1.14% | 1,804,038 | - |
| 447 | ANGO | AngioDynamics, Inc. | 647.68M | -1.14% | 304,344 | 320.17M |
| 448 | KIDS | OrthoPediatrics Corp. | 644.91M | -0.40% | 177,313 | 252.72M |
| 449 | STLN | Starling Oncology, Inc. | 643.09M | -2.17% | 1,212,861 | 587.24M |
| 450 | NVCT | Nuvectis Pharma, Inc. | 621.66M | 0.63% | 102,595 | - |
| 451 | BWAY | BrainsWay Ltd. | 621.09M | -5.09% | 186,647 | 60.70M |
| 452 | SPRY | ARS Pharmaceuticals, Inc. | 620.55M | 10.44% | 2,501,428 | 116.93M |
| 453 | CTKB | Cytek Biosciences, Inc. | 616.12M | 1.07% | 496,791 | 206.71M |
| 454 | ASMB | Assembly Biosciences, Inc. | 611.02M | -8.92% | 303,619 | 74.85M |
| 455 | MDXG | MiMedx Group, Inc. | 610.74M | -1.87% | 897,496 | 355.17M |
| 456 | TLRY | Tilray Brands, Inc. | 607.55M | -4.07% | 3,066,457 | 915.45M |
| 457 | AUTL | Autolus Therapeutics plc | 606.85M | 6.05% | 3,022,120 | 117.39M |
| 458 | ARVN | Arvinas, Inc. | 601.55M | 2.56% | 581,798 | 316.70M |
| 459 | CTEV | Claritev Corporation | 599.09M | -7.27% | 182,600 | 994.67M |
| 460 | CERS | Cerus Corporation | 598.53M | -0.34% | 2,948,324 | 221.55M |
| 461 | CRMD | CorMedix Inc. | 597.83M | 1.72% | 2,166,820 | 462.25M |
| 462 | DCTH | Delcath Systems, Inc. | 591.61M | 1.91% | 531,456 | 95.42M |
| 463 | ALT | Altimmune, Inc. | 583.55M | 2.04% | 4,011,927 | 31.00K |
| 464 | PRLD | Prelude Therapeutics Incorporated | 579.86M | 1.44% | 265,095 | 22.42M |
| 465 | ARTV | Artiva Biotherapeutics, Inc. | 573.97M | 2.53% | 288,358 | 251.00K |
| 466 | EIKN | Eikon Therapeutics, Inc. | 567.11M | -5.25% | 414,945 | - |
| 467 | OVID | Ovid Therapeutics Inc. | 564.41M | 2.12% | 1,746,740 | 1.58M |
| 468 | PRME | Prime Medicine, Inc. | 563.96M | 2.59% | 1,247,822 | 4.07M |
| 469 | TCMD | Tactile Systems Technology, Inc. | 557.02M | 1.61% | 296,498 | 350.31M |
| 470 | OABI | OmniAb, Inc. | 555.39M | 13.02% | 18,087,933 | 38.46M |
| 471 | KYTX | Kyverna Therapeutics, Inc. | 553.50M | 9.55% | 1,027,740 | - |
| 472 | CTNM | Contineum Therapeutics, Inc. | 546.64M | 2.40% | 2,097,224 | - |
| 473 | ZURA | Zura Bio Limited | 544.31M | 1.97% | 617,015 | - |
| 474 | AQST | Aquestive Therapeutics, Inc. | 538.44M | 0.94% | 3,326,234 | 54.09M |
| 475 | ANL | Adlai Nortye Ltd. | 533.60M | 0.68% | 275,828 | 19.54M |
| 476 | CCCC | C4 Therapeutics, Inc. | 524.70M | 0.59% | 1,898,277 | 35.04M |
| 477 | SRTA | Strata Critical Medical, Inc. | 521.95M | - | 531,841 | 255.98M |
| 478 | MPLT | MapLight Therapeutics, Inc. | 521.52M | -4.30% | 620,185 | - |
| 479 | EVMN | Evommune, Inc. | 517.16M | -2.73% | 332,099 | 10.00M |
| 480 | FLGT | Fulgent Genetics, Inc. | 513.44M | 0.54% | 242,906 | 323.93M |
| 481 | EOLS | Evolus, Inc. | 513.21M | -4.72% | 610,175 | 316.49M |
| 482 | RLMD | Relmada Therapeutics, Inc. | 508.82M | -0.63% | 955,697 | - |
| 483 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 484 | ENTX | Entera Bio Ltd. | 502.11M | 0.35% | 304,348 | 42.00K |
| 485 | BLSM | BlossomHill Therapeutics, Inc. | 501.94M | 1.24% | 190,638 | - |
| 486 | EVH | Evolent Health, Inc. | 498.59M | -5.77% | 3,588,796 | 2.10B |
| 487 | NPCE | NeuroPace, Inc. | 490.15M | -3.32% | 197,356 | 106.99M |
| 488 | CABA | Cabaletta Bio, Inc. | 489.99M | 5.09% | 7,634,637 | - |
| 489 | RZLT | Rezolute, Inc. | 488.90M | 1.74% | 533,536 | - |
| 490 | NRC | NRC Health | 481.54M | 2.74% | 118,250 | 140.00M |
| 491 | BIOA | BioAge Labs, Inc. | 477.33M | -1.89% | 670,893 | 10.36M |
| 492 | QTTB | Q32 Bio Inc. | 474.82M | 5.28% | 292,470 | 53.74M |
| 493 | CLPT | ClearPoint Neuro, Inc. | 472.82M | 1.04% | 359,105 | 42.28M |
| 494 | OCGN | Ocugen, Inc. | 466.28M | 1.85% | 2,205,305 | 4.58M |
| 495 | DNA | Ginkgo Bioworks Holdings, Inc. | 465.99M | 1.91% | 685,924 | 132.42M |
| 496 | PRTA | Prothena Corporation plc | 455.87M | 0.23% | 365,214 | 54.53M |
| 497 | PBYI | Puma Biotechnology, Inc. | 455.29M | -0.11% | 191,627 | 231.24M |
| 498 | SGHT | Sight Sciences, Inc. | 453.93M | 1.23% | 389,956 | 83.38M |
| 499 | LRMR | Larimar Therapeutics, Inc. | 450.93M | -0.92% | 880,871 | - |
| 500 | BNTC | Benitec Biopharma Inc. | 449.01M | 4.06% | 69,098 | - |